Authors

Dr. Bucci, a private practitioner in Wilkes-Barre, PA.

Frank J. Weinstock, MD, FACS

Frank Joseph Goes, MD

Fred Crawford, MD

Fred Gebhart

The author is a correspondent for <I>Urology Times</I>, a sister publication.

Sauder has been the managing director and chief physician of the Charlottenklinik für Augenheilkunde in Stuttgart, Germany, and a professor in the Department of Ophthalmology of the University of Mannheim since 2006.

e: prof.sauder.charlottenklinik@gmail.com

Gary D. Novack, PhD

Gary W. Jerkins, MD

Gaynor Fries

Gábor Holló, MD, PhD, DSc

Geoffrey Cooper, MD, FACS

Dr. Cooper, a comprehensive ophthalmologist in solo practice in Richmond, VA.

George H.H. Beiko, BM, BCh, FRCSC

Dr. Beiko is in private practice in St. Catharine's, Ontario, Canada.

George L. Mayo, MD

George L. Mayo, MD
Medical School
Department of Ophthalmology MSC 6230
The University of Texas Health Science Center at San Antonio

George L. Spaeth, MD

George Magrath, MD

Patient enrollment complete in phase 3 trial of OPGx-LCA5 for LCA5-associated inherited retinal disease

2 months ago

Patient enrollment is complete in a phase 3 registrational, or pivotal, trial to evaluate OPGx-LCA5, a gene therapy that is under investigation for treating Leber congenital amaurosis type 5-associated inherited retinal disease.

George N. Magrath, MD, MBA, MS

Gerd Auffarth, Ph.D., MD,